Notes / Company

Influx Healthtech Ltd.

INFLUX ISIN INE0MYZ01012 Pharmaceuticals

Fundamentals

Market cap: ₹661 cr
P/E: 32.16×
ROE: 36.98%
Debt / equity: 0.01
52-week range: 120.00 — 298.75

Research on Tijori Finance

Company snapshot

Influx Healthtech Ltd.

Pharmaceuticals

₹578 cr

P/E 28.15×

Latest quarter · Mar 2026

Sales₹80 cr

Net profit₹11 cr

Op. margin+19.0%

EPS₹4.56

Strength & growth

Debt / equity0.01×

Current ratio1.45×

The timeline — 1 note on Influx Healthtech Ltd.

May 2026

22 May 26 · 8:46 PM IST Brief

Brief · Concalls · Micro cap

Influx Healthtech walks back FY27 revenue doubling goal

The company now targets 25-30% growth, citing client mix shifts and facility ramp-up timelines.

Verify on exchange NSE filings for INFLUX Tijori Finance company page